chartexchange

DRTSW
Alpha Tau Medical Ltd. Warrant
stockNASDAQWarrant

Market OpenNov 19, 2026 10:51:14 AM EST
1.46USD-19.780%(-0.36)139,138
1.3200Bid1.8900Ask0.5700Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
Jerusalem, Israel
Previous Close
$1.82
Beta
3.66
52-Week High
$4.62 2026-09-17
52-Week Low
$0.28 2025-11-20
SMA 50
$3.49
SMA 200
$2.46
Avg. Vol 10D
90,482
Avg. Vol 30D
44,966
Avg. Vol 90D
47,062
Relative Vol
3.09
64.10M
394
DRTSW Profile

alpha tau medical (http://www.alphataumedical.com/) focuses on research, development and commercialization of alpha dart (diffusing alpha-emitters radiation therapy) for the treatment of solid cancer tumors. alpha dart technology, initially developed at tel aviv university, was shown to be effective and safe for treating different types of cancer in multiple animal studies. the company is running its first clinical trial in several sites in the eu. breakthrough technology for cancer treatment the alpha dart breakthrough technology utilizes alpha radiation to treat cancer and enables highly potent and conformal radiotherapy. alpha dart treats solid tumors with interstitial radioactive seeds that continually release short-lived alpha emitting atoms into the tumor.

DRTSW Performance
PeriodPriceDateChangeBeta
1W2.772026-11-12-38.99%16.203
1M2.952026-10-19-42.71%4.465
3M3.902026-08-19-56.67%3.966
6M2.692026-05-19-37.17%3.622
1Y0.282025-11-19+503.57%3.661
2Y0.172024-11-19+884.27%—
5Y0.382022-03-09+344.39%0.979
DRTSW Stock Summary

Alpha Tau Medical Ltd. Warrant (NASDAQ:DRTSW) stock price today is $1.69, and today's volume is 139,138. DRTSW is down 7.143% today. The 30 day average volume is 44,966. DRTSW market cap is $39.56M with 23.41M shares outstanding.